相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adenosine A2A Receptor Ligation Inhibits Osteoclast Formation
Aranzazu Mediero et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis
Junpei Teramachi et al.
LABORATORY INVESTIGATION (2011)
Functional selectivity of adenosine receptor ligands
Dennis Verzijl et al.
PURINERGIC SIGNALLING (2011)
Adenosine A1 Receptors Regulate Bone Resorption in Mice Adenosine A1 Receptor Blockade or Deletion Increases Bone Density and Prevents Ovariectomy-Induced Bone Loss in Adenosine A1 Receptor-Knockout Mice
Firas M. Kara et al.
ARTHRITIS AND RHEUMATISM (2010)
Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function
Firas M. Kara et al.
FASEB JOURNAL (2010)
Characterization of the mouse tartrate-resistant acid phosphatase (trap) gene promoter
S.V. Reddy et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Methotrexate-how does it really work?
Edwin S. L. Chan et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts
Fumiyo Ikeda et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Formation of osteoclast-like cells from peripheral blood of periodontitis patients occurs without supplementation of macrophage colony-stimulating factor
Stanley T. S. Tjoa et al.
JOURNAL OF CLINICAL PERIODONTOLOGY (2008)
Free soluble receptor activator of nuclear factor-κb ligand in gingival crevicular fluid correlates with distinct pathogens in periodontitis patients
Dimitra Sakellari et al.
JOURNAL OF CLINICAL PERIODONTOLOGY (2008)
The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner
Alessandro Sorrentino et al.
NATURE CELL BIOLOGY (2008)
Osteoclasts Are Active in Bone Forming Metastases of Prostate Cancer Patients
Ilaria Roato et al.
PLOS ONE (2008)
C-Jun N-terminal kinase regulates adenosine A1 receptor-mediated synaptic depression in the rat hippocampus
Tyson B. Brust et al.
NEUROPHARMACOLOGY (2007)
Adenosine inhibition of lipopolysaccharide-induced interleukin-6 secretion by the osteoblastic cell line MG-63
Joseph M. Russell et al.
CALCIFIED TISSUE INTERNATIONAL (2007)
NF-κB p50 and p52 regulate receptor activator of NF-κB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1
Teruhito Yamashita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Ubiquitin-mediated activation of TAK1 and IKK
A. Adhikari et al.
ONCOGENE (2007)
TAK1-dependent signaling requires functional interaction with TAB2/TAB3
Arnaud Besse et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-κB transactivation by RANKL
H. Huang et al.
CELL DEATH AND DIFFERENTIATION (2006)
Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteoprotegerin
BAJ Evans et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
TAB2, TRAF6 and TAK1 are involved in NF-κB activation induced by the TNF-receptor, Edar and its adaptator Edaradd
A Morlon et al.
HUMAN MOLECULAR GENETICS (2005)
Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis
N Kim et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation
F Ikeda et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
G16-mediated activation of nuclear factor κB by the adenosine A1 receptor involves c-Src, protein kinase C, and ERK signaling
AMF Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos
K Matsuo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Etiology of Paget's disease and osteoclast abnormalities
SV Reddy
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by β3 integrin
R Faccio et al.
JOURNAL OF CELL BIOLOGY (2003)
c-Fms and the αvβ3 integrin collaborate during osteoclast differentiation
R Faccio et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts
H Takayanagi et al.
DEVELOPMENTAL CELL (2002)
JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms
JP David et al.
JOURNAL OF CELL SCIENCE (2002)
Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis
T Hirayama et al.
RHEUMATOLOGY (2002)
Bone destruction in arthritis
EM Gravallese
ANNALS OF THE RHEUMATIC DISEASES (2002)
Receptor activator of NF-κB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6
J Mizukami et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Carbonic anhydrase II is an AP-1 target gene in osteoclasts
JP David et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2001)
Interleukin-1 (IL-1) receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathway
G Takaesu et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Mice lacking β3 integrins are osteosclerotic because of dysfunctional osteoclasts
KP McHugh et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D-3 and RANKL
SD Neale et al.
BONE (2000)
分享论文
